No Data
HAOHAI BIOTEC (06826) spent 0.4923 million HKD to buy back 0.02 million shares on January 10.
HAOHAI BIOTEC (06826) announced that on January 10, 2025, the company invested 0.4923 million...
HAOHAI BIOTEC (06826) spent HKD 0.6519 million on January 9 to repurchase 0.026 million shares.
HAOHAI BIOTEC (06826) announced that it will spend 0.6519 million Hong Kong dollars to repurchase shares on January 9, 2025...
HAOHAI BIOTEC (06826.HK) spent 0.254 million Hong Kong dollars to repurchase 0.01 million shares on January 8.
On January 8, Gelonghui reported that HAOHAI BIOTEC (06826.HK) announced it spent HKD 0.254 million to repurchase 0.01 million shares on January 8, 2025, with a repurchase price of HKD 25.4 per share.
HAOHAI BIOTEC (06826.HK) repurchased 0.039 million shares on January 2, spending 1.005 million Hong Kong dollars.
Gelonghui, January 2nd | HAOHAI BIOTEC (06826.HK) announced that on January 2, 2025, it spent 1.005 million Hong Kong dollars to repurchase 0.039 million shares at a price of 25.4-26 Hong Kong dollars per share.
Shanghai Haohai Biological Technology (688366.SH): Cumulatively repurchased 0.21% of shares.
On January 2, Gelonghui reported that Shanghai Haohai Biological Technology (688366.SH) announced that by December 2024, the company had cumulatively repurchased 354,596 A-shares through centralized price bidding, accounting for 0.15% of the company's total share capital of 233,193,695 shares, with a maximum Fill Price of 63.20 yuan/share, a minimum Fill Price of 60.58 yuan/share, and a total purchase amount of 21,850,342.17 yuan (excluding stamp duty, transaction commission, and other trading costs). As of December 31, 2024, the company had cumulatively repurchased A-shares through centralized price bidding.
Statistics on the abnormal share of Zhitong Hong Kong Stock Connect | January 1.
Statistics on abnormal changes in the proportion of the Stock Connect as of December 31, 2024.
Investors Interested In Shanghai Haohai Biological Technology Co., Ltd.'s (HKG:6826) Earnings
